Key result
Systolic BP U-curve in very elderly hypertensives linked to lowest mortality at 140-149 mmHg.
Why the study?
Contradictory evidence regarding the 'the lower the better' hypothesis in the very elderly has led to unclear blood pressure treatment targets.
Does lower baseline blood pressure reduce ischemic stroke, myocardial infarction, and mortality in very elderly patients taking antihypertensives?
Cohort (n=374,250)
Yes
Does lower baseline blood pressure reduce ischemic stroke, myocardial infarction, and mortality in very elderly patients taking antihypertensives?
Effect estimate: HR 0.961 (95% CI 0.937-0.985)
In very elderly hypertensive patients, blood pressure below certain nadirs (SBP <120-140 mmHg) provides no further cardiovascular benefit and may increase mortality risk, challenging strict 'lower is better' targets.
Suggests caution lowering SBP below 140 mmHg in very elderly; leaves open confirmation by randomized trials.
BACKGROUND: In the very elderly, "the lower the better" hypothesis has constantly been contradicted by randomized control trials and various cohort studies, but inconsistency in results led to unclear blood pressure treatment targets. This study aimed to assess the relationship between baseline blood pressure (BP) and ischemic stroke, myocardial infarction, and all-cause mortality in very elderly people treated for hypertension. METHODS: This large population-based retrospective cohort study was based on the national claims database of the Korean National Health Insurance System, which covers the entire Korean population. 374,250 participants aged ≥ 75 years taking antihypertensive agents were recruited, excluding patients with a history of previous ischemic stroke or myocardial infarction. RESULTS: Systolic BP (SBP) followed a J curve for ischemic stroke and a U curve for all-cause mortality, with nadir ranges of 120 to 129 mmHg and 140 to 149 mmHg, respectively. While increasing diastolic BP (DBP) generally resulted in higher HRs for ischemic stroke, HRs for myocardial infarction and all-cause mortality significantly increased only when DBP was ≥ 80 mmHg and ≥ 90 mmHg, respectively. The SBP/DBP combination analysis showed that even with SBP < 130 mmHg, higher DBP ≥ 90 mmHg had higher HRs for all three outcomes compared to the reference group (130 to 149 / < 80 mmHg). CONCLUSIONS: There were no further benefits or even harm below certain BP levels for ischemic stroke, myocardial infarction, and all-cause mortality in very elderly hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Song et al. (2021) conducted a cohort in Hypertension (n=374,250). Systolic blood pressure 140-149 mmHg vs. Systolic blood pressure 120-129 mmHg was evaluated on All-cause mortality (HR 0.961, 95% CI 0.937-0.985). In very elderly hypertensive patients, systolic blood pressure followed a U-curve for all-cause mortality with a nadir at 140 to 149 mmHg (HR 0.961), indicating potential harm at lower blood pressure levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: